EUR 169,00
Cantidad disponible: 5 disponibles
Añadir al carritoCondición: New. Daniel A. Erlanson is the co-founder and President of Carmot Therapeutics, Inc., which is developing fragment-based approaches to address unmet needs in drug discovery. Prior to Carmot, Dr. Erlanson worked in medicinal chemistry and technology development a.